Kazuya Nagao, Takao Kato, Hidenori Yaku, Takeshi Morimoto, Kenji Aida, Shiori Kawakami Maruichi, Yasutaka Inuzuka, Yodo Tamaki, Erika Yamamoto, Yusuke Yoshikawa, et al. Differential Prognostic Impact of Clinical Congestion between Preserved versus Reduced Ejection Fraction in Patients Hospitalized for Acute Decompensated Heart Failure: Findings from the Japanese KCHF registry. Journal of Cardiac Failure. 2024. E-pub
Hamatani Y, Iguchi M, Kato T, Inuzuka Y, Tamaki Y, Ozasa N, Kawaji T, Esato M, Tsuji H, Wada H, et al. Importance of non-cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction. ESC Heart Fail. 2024. E-pub
Wei Xiong, Yugo Yamashita, Takeshi Morimoto, Toru Takase, Seiichi Hiramori, Kitae Kim, Maki Oi, Masaharu Akao, Yohei Kobayashi, Po-Min Chen, et al. Initial hemodynamic status and Acute Mortality in Cancer patients with Acute Pulmonary Embolism: from the COMMAND VTE Registry. Journal of Thrombosis and Thrombolysis. 2024
Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan. 2024. E-pub
Tanaka M, Kato T. Development of Interpretable Prediction Model Based on Machine Learning for Worsening Heart Failure in Patients with Acute Heart Failure. JCS2024. 2024
Nagao K, Kato T. Distinct Prognostic Impact of Clinical Congestion Based on Left Ventricular Ejection Fraction in Patients Hospitalized for Decompensated Heart Failure. AHA 2023. 2023
Tamaki, Kato. Effect of Metformin in Diabetic Patients Hospitalized for Acute Decompensated Heart Failure. JCS2023. 2023
Tanaka, Kohjitani, Yamamoto, Kato. Prediction of in-hospital mortality in patients with acute heart failure by using machine learning methods. JCS2023. 2023
Aida, Nagao, Kato. Prognostic value of the severity of clinical congestion in patients hospitalized for decompensated heart failure: Findings from KCHF registry. JCS2023. 2023
Genome Editing and Pathological Cardiac Hypertrophy. In: Xiao, J. (eds) Genome Editing in Cardiovascular and Metabolic Diseases. Advances in Experimental Medicine and Biology, vol 1396. Springer, Singapore.
2022
「心臓形態と心機能から見た高血圧患者のリスク同定」 Precision Medicine
北陸社 2022
Introduction to the ‘Partnerships to tackle Cardiovascular Disorders” article collection. An article collection, in support of SDG17: Partnerships to achieve the goal BMC Cardiovascular Disorders Article Collection
BMC Cardiovascular Disorders Article Collection 2022
「心不全における心臓、肝臓、腎臓のメタボロミクス」 Precision Medicine
北陸社 2021
Proposed Three Axes for the Assessment and Treatment of HFmrEF and HFpEF
(JCS 2024 Plenary session. Exploring New Frontiers In the Management for HFmrEF and HFpEF: Moving Beyond LVEF to a Broder Therapeutic Approach 2024)
Commentary from a Japanese investigator for Trial of the Year: CHAP trial
(日本臨床試験学会 第15回学術集会総会 JCTR-SCTジョイントシンポジウム 2024)
Prediction of in-hospital mortality and worsening heart failure of patients with acute heart failure by using latest machine learning models
(第27回日本心不全学会学術集会 シンポジウム 心不全診療における AI の可能性 2023)
2011 - 日本心臓核医学会 第10回日本心臓核医学会Young Investigator’s Award 最優秀賞.
2009/07 - IACS Young Investigator’s Award of International Academy of Cardiovascular Sciences Japan Section, the 8th annual meeting of Japan Section of IACS. 1等賞
所属学会 (1件)：
臨床試験学会・臨床薬理学会・日本内科学会(専門医)・日本循環器学会(特別正会員FJCS・専門医)・心臓病学会(特別正会員FJCC)・日本心不全学会(代議員)・日本心臓核医学会(評議員)・日本心血管インターベンション学会・日本ミトコンドリア学会(評議員)・日本心臓リハビリテーション学会・American Heart Association・European Society of Cardiology (FESC)
